Entitlement Offer Booklet
Released
Released
Announcement PDF
KGL Resources Limited
(ACN 082 658 080)
Offer Booklet
1 for 8 pro-rata traditional non-renounceable entitlement offer of fully paid ordinary shares in
the Company at an Offer Price of $0.095 per New Share.
The Offer closes at 5.00pm (Sydney time) on 26 March 2025.
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
If you are an Eligible Shareholder, this Offer Booklet requires your immediate attention. It is an
important document which is accompanied by a personalised Entitlement and Acceptance Form and
both should be read in their entirety. This Offer Booklet is not a prospectus under the Corporations
Act and has not been lodged with ASIC. Please call your stockbroker, solicitor, accountant, financial
adviser or other professional adviser or the Company’s Shareholder information line on 1800 881 526
from 8.30am to 5.30pm (Sydney time) Monday to Friday. The Offer website can be found here.
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
IMPORTANT NOTICES
Defined terms and abbreviations used in this Offer Booklet are set out in the
glossary in Section 7.
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES.
No action has been taken to register or qualify the Offer, the Entitlements or the
New Shares, or otherwise permit the public offering of the New Shares, in any
jurisdiction other than Australia.
The distribution of this Offer Booklet (including an electronic copy) outside
Australia, New Zealand and other jurisdictions in which such distribution is
This Offer Booklet has been prepared and issued by KGL Resources Limited (ACN 082
permitted (see Section 6.12), is restricted by law. If you come into possession of
658 080) (Company) and is dated 17 March 2025. This Offer Booklet relates to the
the information in this booklet, you should observe such restrictions and should
entitlement offer by the Company of New Shares to raise gross proceeds of up to
seek your own advice on such restrictions. Any non‑compliance with these
approximately $7.7 million.
restrictions may contravene applicable securities laws.
The Offer is being made in Australia pursuant to section 708AA of the Corporations Act,
Foreign exchange control restrictions or restrictions on remitting funds from your
which allows entitlement offers to be made to investors without a prospectus. This Offer
country to Australia may apply. Your Application for New Shares is subject to all
Booklet does not contain all of the information which an investor may require to make
requisite authorities and clearances being obtained for the Company to lawfully
an informed investment decision, nor does it contain all the information which would be
receive your Application Monies.
required to be disclosed in a prospectus, product disclosure statement or other
disclosure document under the Corporations Act. The information in this Offer Booklet
New Zealand
does not constitute financial product advice and does not take into account your
The New Shares are not being offered or sold to the public within New Zealand
investment objectives, financial situation or particular needs.
other than to existing Shareholders with registered addresses in New Zealand to
This Offer Booklet should be read in its entirety before you decide to participate in
the Offer. This Offer Booklet is not a prospectus, product disclosure statement or
other disclosure document under the Corporations Act and has not been lodged
with ASIC.
As this Offer is not being made under a prospectus, investment statement or product
disclosure statement, it is important for Eligible Shareholders to read carefully and
understand this Offer Booklet and the information about the Company and the Offer that
is made publicly available. In particular, please refer to the materials in this Offer
Booklet (including the ASX Announcements in Section 5), the Company's annual
reports and other ASX announcements made available at www.kglresources.com.au
(including the Company's 2024 annual report which was released to ASX on 24
September 2024 and the Company’s 2025 half year financial report which was released
to ASX on 6 March 2025), and other ASX announcements which may be made by the
Company after publication of this Offer Booklet.
By returning a completed personalised Entitlement and Acceptance Form and making a
payment through EFT, or making a payment through BPAY®, in either case accordance
with the instructions on your personalised Entitlement and Acceptance Form, you
acknowledge that you have read this Offer Booklet and you have acted in accordance
with and agree to the terms of the Offer detailed in this Offer Booklet.
No overseas offering
whom the offer of New Shares is being made in reliance on the Financial Markets
Conduct (Incidental Offers) Exemption Notice 2021 (New Zealand).
This Offer Booklet has been prepared in compliance with Australian law and has
not registered, filed with, or approved by, any New Zealand regulatory authority
under the Financial Markets Conduct Act 2013 (New Zealand). This Offer Booklet
is not a product disclosure statement under New Zealand law and is not required
to, and may not, contain all the information that a product disclosure statement
under New Zealand law is required to contain.
United States disclaimer
This Offer Booklet, the accompanying Entitlement and Acceptance Form, and the
accompanying ASX Announcements (including the Company's Investor
Presentation included as part of this Offer Booklet) do not constitute an offer or
invitation to sell, or the solicitation of an offer to buy, any securities in the United
States.
Neither this Offer Booklet nor the accompanying Entitlement and Acceptance Form
may be distributed or released in the United States. Neither the Entitlements nor
the New Shares offered in the Offer have been, or will be, registered under the US
Securities Act or the securities laws of any state or other jurisdiction of the United
States.
Accordingly, the Entitlements may not be issued to, or taken up or exercised by,
This Offer Booklet, the accompanying Entitlement and Acceptance Form, and the
and the New Shares may not be offered or sold directly or indirectly to, persons in
accompanying ASX Announcements (including the Company's Investor
the United States or persons who are acting for the account or benefit of a person
Presentation included as part of this Offer Booklet) may not be distributed or
in the United States (to the extent such persons hold such securities and are
released in the United States and do not constitute an offer to sell, or the
acting for the account or benefit of a person in the United States), unless they
solicitation of an offer to buy, any securities in the United States or in any place in
have been registered under the US Securities Act or offered or sold in a
which, or to any person to whom, it would not be lawful to make such an offer or
transaction exempt from, or not subject to, the registration requirements of the US
invitation. In particular, this Offer Booklet does not constitute an offer to Ineligible
Securities Act and any other applicable securities laws of any state or other
Shareholders and may not be distributed in the United States and the New Shares
jurisdiction of the United States. The New Shares to be offered and sold in the
may not be offered or sold, directly or indirectly, to persons in the United States
Offer pursuant to this Offer Booklet may only be offered and sold outside the
except pursuant to an exemption from, or in a transaction not subject to, the
United States in 'offshore transactions' (as defined in Rule 902(h) under the US
registration requirements of the U.S. Securities Act of 1933, as amended (US
Securities Act) in reliance on Regulation S under the US Securities Act.
Securities Act).
United Kingdom
This Offer Booklet is not to be distributed in, and no offer of New Shares is to be
made, in countries other than Australia and New Zealand unless the Company, in
Neither the information in this Offer Booklet, nor any other document relating to the
its discretion, is satisfied that the Offer may be made in compliance with all
Offer, has been delivered for approval to the Financial Conduct Authority in the
applicable laws. If you are a Shareholder with a registered address in the United
States of America, Singapore, Hong Kong, the British Virgin Islands, Ireland,
Germany, or the United Kingdom please refer to Section 6.12 for further
information in this regard.
United Kingdom and no prospectus (within the meaning of section 85 of the
Financial Services and Markets Act 2000, as amended) has been published or is
intended to be published in respect of the New Shares.
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
In the United Kingdom, this Offer Booklet is being distributed only to, and is directed
at, persons: (a) who fall within Article 43 (members or creditors of certain bodies
performance are also forward-looking statements. Any forecasts or other forwardlooking statements contained in this Offer Booklet are subject to known and
unknown risks and uncertainties and may involve significant elements of subjective
corporate) of the Financial Services and Markets Act 2000 (Financial Promotion)
judgement and assumptions as to future events which may or may not be correct.
Order 2005, as amended; or (b) to whom it may otherwise be lawfully
There are usually differences between forecast and actual results because events
communicated (together, Relevant Persons). The investments to which this Offer
and actual circumstances frequently do not occur as forecast and these differences
Booklet relates are available only to, and any invitation, offer or agreement to
purchase will be engaged in only with, Relevant Persons. Any person who is not a
Relevant Person should not act or rely on this Offer Booklet or any of its contents.
References to "you" and "your Entitlement"
may be material. The Company does not give any representation, assurance or
guarantee that the occurrence of the events expressed or implied in any forwardlooking statements in this Offer Booklet will actually occur and you are cautioned
not to place undue reliance on forward-looking statements.
To the maximum extent permitted by law, the Company and its related bodies
In this Offer Booklet, references to "you" are references to Eligible Shareholders (as
corporate, and their respective directors, officers, employees, advisors and agents
defined in Section 1.2) and references to "your Entitlement" (or "your Entitlement
(together, the Relevant Parties) disclaim any responsibility for any errors or
and Acceptance Form") are references to the Entitlement (or Entitlement and
omissions in such information, including the financial calculations, projections and
Acceptance Form) of Eligible Shareholders.
forecasts and indications of, and guidance on, future earnings and performance
Times and dates
and financial position. Such forward-looking statements relate to future events and
expectations and are not guarantees of future performance. Such forward-looking
Times and dates in this Offer Booklet are indicative only and may be subject to
statements involve known and unknown risks, uncertainties and other factors and
change. All times and dates refer to Sydney time. Refer to the "Key Dates" section
are subject to significant business, economic and competitive uncertainties and
of this Offer Booklet for more details.
contingencies associated with exploration and/or production, many of which are
Currency
Unless otherwise stated, all dollar values in this Offer Booklet are in Australian
beyond the Company's control, that may cause actual results to differ materially
from those predicted or implied by any forward-looking statements. No
representation or warranty is made by or on behalf of the Company or the Relevant
dollars (AUD).
Parties that any projection, forecast, calculation, forward-looking statement,
Privacy
that actual outcomes will not differ materially from any forward-looking statements.
The Company collects information about each applicant provided on an
Entitlement and Acceptance Form for the purposes of processing the application
and, if the application is successful, to administer the applicant’s holding in the
Company.
assumption or estimate contained in this Offer Booklet should or will be achieved or
Graphs used in this Offer Booklet (including data used in the graphs) are sourced
from third parties and the Company has not independently verified the information.
Although reasonable care has been taken to ensure that the information in this
Offer Booklet is accurate and that the opinions expressed are fair and reasonable,
they are based on assumptions and contingencies which are subject to change
By paying for your New Shares, you will be providing personal information to the
without notice and involve known and unknown risks, uncertainties and other
Company (directly or through the Company's Share Registry). The Company
factors, many of which are beyond the control of the Company and the Relevant
collects, holds and will use that information to assess your application. The
Parties, and no reliance can be placed for any purpose whatsoever on the
Company collects your personal information to process and administer your
information contained in this Offer Booklet or on its completeness. Actual results
shareholding in the Company and to provide related services to you. The
and developments may differ materially from those expressed or implied by these
Company may disclose your personal information for purposes related to your
forward-looking statements, depending on a variety of factors.
shareholding in the Company, including to the Company's Share Registry, the
Company's related bodies corporate, agents, contractors and third party service
providers, including mailing houses and professional advisers, and to ASX and
regulatory bodies. You can obtain access to personal information that the
Company holds about you. To make a request for access to your personal
information held by (or on behalf of) the Company, please contact the Company
through the Company's Share Registry.
Recipients of this Offer Booklet are strongly cautioned not to place undue reliance
on forward-looking statements, particularly in light of the significant volatility,
uncertainty and disruption caused by the current economic climate and the
geopolitical tensions across a number of areas worldwide. Refer to the "Key Risk
Factors" section of the Company's Investor Presentation included in Section 5 for a
summary of certain general and specific risk factors that may affect the Company.
Governing law
Except as required by law or regulation (including the ASX Listing Rules), the
This Offer Booklet, the Offer, and the contracts formed on acceptance of the Entitlement
whether as a result of new information, future events or results or otherwise.
and Acceptance Forms are governed by the laws applicable in Queensland, Australia.
Company undertakes no obligation to provide any additional or updated information
Each applicant submits to the non-exclusive jurisdiction of the courts of Queensland,
Past performance
Australia and courts competent to hear appeals from those courts.
Investors should note that past performance, including the past share price
Forward-looking statements
performance of the Company and the pro forma historical information in the
This Offer Booklet includes forward-looking statements. Forward-looking
purposes only and cannot be relied upon as an indicator of (and provides no
statements can generally be identified by the use of forward-looking words such as
guidance as to) future Company performance including future share price
“expect”, “forecast”, “estimate”, “like”, “anticipate”, “project”, “opinion”, "outlook",
performance. The pro forma historical information is not represented as being
"guidance", “should”, “could”, “may”, “target”, "believe", "intend", "plan" and other
similar expressions within the meaning of securities laws of applicable jurisdictions.
Forward-looking statements include statements about the Company’s plans and
expectations regarding the development of the Jervois Copper Project, statements
regarding the conduct and outcome of the Offer, and sources and uses of funds.
Indications of, and guidance on, future earnings and financial position and
Company's Investor Presentation included in Section 5, is given for illustrative
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
indicative of the Company's views on its future financial condition and/or
performance.
Risks
Refer to the "Key Risk Factors" section of the Company's Investor Presentation
included in Section 5 for a summary of certain general and specific risk factors that
may affect the Company.
Trading in New Shares
The Company and its affiliates and related bodies corporate have no responsibility
and disclaim all liability (to the maximum extent permitted by law) to persons who
trade New Shares they believe will be issued to them before they receive their
holding statements, whether on the basis of confirmation of the allocation provided
by the Company or the Company's Share Registry or failure to maintain your
updated details with the Company's Share Registry or otherwise, or who otherwise
trade or purport to trade New Shares in error or which they do not hold or are not
entitled to.
If you are in any doubt as to these matters you should first consult with your
stockbroker, solicitor, accountant, financial adviser or other professional adviser.
Refer to Section 6 for details.
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
Table of contents
LETTER FROM THE CHAIR
2
SUMMARY OF THE OFFER
4
KEY DATES
4
1.
OVERVIEW OF OFFER
6
2.
SUMMARY OF OPTIONS AVAILABLE TO YOU
10
3.
HOW TO APPLY
12
4.
AUSTRALIAN TAX CONSIDERATIONS
20
5.
ASX ANNOUNCEMENTS (INCLUDING INVESTOR PRESENTATION)
23
6.
ADDITIONAL INFORMATION
24
7.
GLOSSARY
33
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
LETTER FROM THE CHAIR
17 March 2025
Dear Shareholder
As a valued Shareholder, I am pleased to invite you to participate in a 1 for 8 pro-rata traditional nonrenounceable entitlement offer of new fully paid ordinary shares in the Company (New Shares) at an
offer price of $0.095 per New Share (Offer Price) to raise gross proceeds of up to approximately $7.7
million (Offer).
The proceeds of the Offer will be applied principally to progressing the Jervois Project towards
production as follows: 1
•
Corporate financial advisor(s) to deliver project funding required for construction.
•
Project execution, planning and independent technical review.
•
Corporate and site overheads.
•
Initial siteworks enabling critical path activities.
The background to the Offer and the key risks facing the Company in the next 12 to 24 months are
described in more detail in the Company's Investor Presentation lodged with ASX on 6 March 2025
(and included in this Offer Booklet in Section 5).
The Offer is not underwritten, and is subject to a minimum raise condition of $3 million. Funding
received from the minimum raise will primarily be used to progress the funding arrangements for the
Jervois Project and corporate and site overheads. Any funds in excess of the minimum raise will be
applied towards project execution, planning and finalisation of the independent technical review, and
initial siteworks enabling critical path activities. The Board reserves the right to change the allocation
of funds where there are changes, for example, in market conditions, exploration priorities or strategic
objectives.
This Offer Booklet relates to the Offer. Under the Offer, Eligible Shareholders are entitled to acquire 1
New Share for every 8 Shares held at 7.00pm (Sydney time) on 12 March 2025 (Record Date)
(Entitlement). Your Entitlement is set out in your personalised Entitlement and Acceptance Form
which accompanies this Offer Booklet. It is important that you determine whether to take up in whole
or part, or do nothing, in respect of your Entitlement (see Section 2).
Eligible Shareholders have the opportunity to invest at the price of $0.095 per New Share. The issue
price of $0.095 per New Share represents a 5% discount to the closing price of Shares on 5 March
2025 (being the last trading day before announcement of the Offer), and a 3% discount to the TERP
of $0.099. 2
New Shares issued through the Offer will rank equally with existing Shares on issue.
1
An exact breakdown of the use of funds is detailed on slide 8 of the Company’s Investor Presentation lodged with ASX on 6 March 2025 (and
included in this Offer Booklet in Section 5).
The TERP is the theoretical price at which Shares should trade immediately following the ex-date for the Offer assuming 100% take up of the
Offer. The TERP is a theoretical calculation only and the actual price at which Shares trade immediately following the ex-date for the Offer will
depend on many factors and may not be equal to the TERP. The TERP is calculated by reference to the Company’s closing price of $$0.102 per
Share on 5 March 2025, being the last trading day prior to the announcement of the Offer.
2
2
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
Substantial Shareholder, KMP Investments Pte. Ltd. (KMP), which has an interest in the Company of
approximately 35.14%, has committed to take up its Entitlement in full. 3
Entitlements under the Offer are non-renounceable and will not be tradeable on ASX or otherwise
transferable. If you do not take up your Entitlement in full, you will not receive any value in respect of
that part of the Entitlement that you do not take up.
The Offer closes at 5.00pm (Sydney time) on 26 March 2025.
If you would like to exercise your Entitlement to increase your shareholding in the Company, you will
need to either complete and return your personalised Entitlement and Acceptance Form together with
the requisite Application Monies via EFT, or alternatively pay your Application Monies using BPAY®,
so that they are received by the Company's Share Registry by 5.00pm (Sydney time) on 26 March
2025. The Offer website can be found here.
Please carefully read this Offer Booklet in its entirety and consult your stockbroker, solicitor,
accountant, financial adviser or other professional adviser before making your investment decision. In
particular, you should read and consider the "Key Risk Factors" section of the Company's Investor
Presentation included in Section 5 which contains a summary of some of the key risks associated with
an investment in the Company.
If you have any questions in respect of the Offer, please call the Company’s Shareholder information
line on 1800 881 526 from 8.30am to 5.30pm (Sydney time) Monday to Friday.
On behalf of the Board and management team of the Company, I invite you to consider this
investment opportunity and thank you for your ongoing support.
Yours faithfully
Jeffrey Gerard
Chair
KGL Resources Limited
3
The Company sought and received relief from ASIC such that Chapter 6 of the Corporations Act applies to the Company as if Item 10(b) of
section 611 of the Corporations Act were modified by inserting after the words “offers are made to every person who holds securities” the words
“with a registered address in Australia or New Zealand”.
3
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
SUMMARY OF THE OFFER
Ratio
1 New Share for every 8 existing Shares held
Offer Price for New Shares
$0.095 per New Share
Size
Up to 81,014,131 New Shares (subject to rounding of
Entitlements)
Gross proceeds (minimum)
$3 million
Gross proceeds (maximum)
Up to approximately $7.7 million
KEY DATES
Event
Date
Announcement of the Offer
Thursday, 6 March 2025 (before
market open)
"Ex" date
Tuesday, 11 March 2025
Record date for Offer (7.00pm (Sydney time)) (Record Date)
Wednesday, 12 March 2025
Offer Booklet and personalised Entitlement and Acceptance
Forms despatched, and announcement of despatch
Monday, 17 March 2025
Offer opens
Monday, 17 March 2025
Last day to extend the Closing Date for the Offer
Friday, 21 March 2025
Closing Date for the Offer (5.00pm (Sydney time)) 4
Wednesday, 26 March 2025
Securities quoted on a deferred settlement basis (from market
open)
Thursday, 27 March 2025
Announcement of results of the Offer (before market open)
Monday, 31 March 2025
Settlement of the Offer
Tuesday, 1 April 2025
Allotment of New Shares issued under the Offer (before 12.00pm
(Sydney time))
Wednesday, 2 April 2025
Normal trading on ASX for New Shares issued under the Offer
commences (at market open)
Thursday, 3 April 2025
4
Eligible Shareholders who wish to take up all or a part of their Entitlement must complete and return their personalised Entitlement and
Acceptance Form with the requisite Application Monies via EFT, or pay their Application Monies via BPAY®, by following the instructions set out
on the personalised Entitlement and Acceptance Form so that they are received by the Company's Share Registry by no later than 5.00pm
(Sydney time) on 26 March 2025. Eligible Shareholders should refer to Section 2 for options available to them to deal with their Entitlement.
4
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
Event
Date
Despatch of holding statements for New Shares issued under the
Offer
Friday, 4 April 2025
The timetable above is indicative only and may change. The Company may amend any of these
dates and times without notice, subject to the Corporations Act, the ASX Listing Rules and other
applicable laws. In particular, the Company reserves the right to extend the Closing Date, to accept
late applications under the Offer (either generally or in particular cases) and to withdraw the Offer
without prior notice. Any extension of the Closing Date will have a consequential effect on the issue
date of New Shares.
The commencement of quotation of New Shares is subject to confirmation from ASX. Cooling off
rights do not apply to an investment in New Shares. You cannot withdraw your application once it has
been accepted. Eligible Shareholders wishing to participate in the Offer are encouraged to follow the
instructions set out on their Entitlement and Acceptance Form as soon as possible after the Offer
opens to ensure their application is received by the Company's Share Registry in time.
Enquiries
If you have any questions, please contact the Company’s Shareholder information line on 1800 881
526 from 8.30am to 5.30pm (Sydney time), Monday to Friday. The Offer website can be found here.
If you have any further questions, you should contact your stockbroker, solicitor, accountant, financial
adviser or other professional adviser.
5
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
1.
OVERVIEW OF OFFER
1.1
Offer
The Offer is an offer of up to approximately 81,014,131 New Shares at the Offer Price of $0.095 per
New Share, to raise up to approximately $7.7 million. All Eligible Shareholders are entitled to
subscribe for 1 New Share for every 8 Shares held at the Record Date, being 7.00pm (Sydney time)
on 12 March 2025.
The proceeds of the Offer will be applied principally to progressing the Jervois Project towards
production as follows: 5
•
Corporate financial advisor(s) to deliver project funding required for construction.
•
Project execution, planning and independent technical review.
•
Corporate and site overheads.
•
Initial siteworks enabling critical path activities.
Eligible Shareholders who take up their full Entitlement may also participate in the top-up facility (TopUp Facility) by applying for additional New Shares in excess of their Entitlement at the Offer Price.
Applications under the Top-Up Facility will (subject to the Company ensuring that no issue of New
Shares occurs that is contrary to law) be uncapped. Additional New Shares under the Top-Up
Facility will only be allocated to Eligible Shareholders if available and to the extent that the Directors
of the Company so determine, in their absolute discretion. If you apply for additional New Shares
there is no guarantee that you will be allocated any additional New Shares.
In particular, an Eligible Shareholder will not be issued any additional New Shares under the Top-Up
Facility if the issue of such additional New Shares would cause the Company or that Eligible
Shareholder to breach any applicable law, including but not limited to section 606 of the Corporations
Act.
The Offer is not underwritten, and is subject to a minimum raise condition of $3 million. Funding
received from the minimum raise will primarily be used to progress the funding arrangements for the
Jervois Project and corporate and site overheads. Any funds in excess of the minimum raise will be
applied towards project execution, planning and finalisation of the independent technical review, and
initial siteworks enabling critical path activities. The Board reserves the right to change the allocation
of funds where there are changes, for example, in market conditions, exploration priorities or strategic
objectives.
The Offer is non‑renounceable. Accordingly, Entitlements do not trade on ASX, nor can they be sold,
transferred or otherwise disposed of.
Substantial Shareholder, KMP, which has an interest in the Company of approximately 35.14%, has
committed to take up its Entitlement in full. 6
The Offer opens on 17 March 2025. This Offer Booklet will be despatched on that same date, along
with a personalised Entitlement and Acceptance Form, to Eligible Shareholders. The Offer is
expected to close at 5.00pm (Sydney time) on 26 March 2025.
5
An exact breakdown of the use of funds is detailed on slide 8 of the Company’s Investor Presentation lodged with ASX on 6 March 2025 (and
included in this Offer Booklet in Section 5).
The Company sought and received relief from ASIC such that Chapter 6 of the Corporations A
Share your feedback
Discover